Safety and tolerability of a 2009 trivalent inactivated split‐virion influenza vaccine in infants, children and adolescents

OBJECTIVE: To evaluate the safety of CSL's split‐virion inactivated trivalent 2009 Southern Hemisphere formulation influenza vaccine (TIV) in children. METHODS: We enrolled 1992 healthy children into three groups: Cohorts A, ≥6 months to <3 years; B, ≥3 years to <9 years; and C, ≥9 years...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Influenza Other Respir Viruses
Autors principals: Lambert, Stephen B., Chuk, Lai‐man R., Nissen, Michael D., Nolan, Terry M., McVernon, Jodie, Booy, Robert, Heron, Leon, Richmond, Peter C., Walls, Tony, Marshall, Helen S., Reynolds, Graham J., Hartel, Gunter F., Hu, Wilson, Lai, Michael H.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2013
Matèries:
Part 1
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5781200/
https://ncbi.nlm.nih.gov/pubmed/23551933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/irv.12107
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars